ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

March 27, 2009

Dial Access Offers Caner Consultation Services

February 21, 1975

In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery

October 5, 1990

AACI Opposes Most Guidelines Proposals But Can’t Agree On Research Based Ceiling

May 2, 1980

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Cost Of Cancer:$40 Billion In 1980, Now Probably Between $50-80 Billion; “The Tip Of The Iceberg”

February 25, 1983